Nippon Shinyaku Co., Ltd.
日本新薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4516
FY2025 · 2026-03-31
| Gross margin | 66.4% |
| Operating margin | 20.8% |
| Net margin | 17.4% |
| Return on equity | 10.2% |
| Return on assets | 8.6% |
| Revenue growth (YoY) | 6.6% |
| EPS (basic) | ¥441 |
| EPS growth (YoY) | -8.8% |
| Current ratio | — |
| Equity ratio | 84.2% |
| Book value / share | ¥3,876.51 |
| Free cash flow | 24,240 M |